Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) Recruiting Phase 4 Trials for Diphtheria Prevention

IndicationsStatusPurposePhase
RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT04535037A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers